Journal of Clinical Microbiology · 2010 · 116 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyDiagnostic MicrobiologyMedical MicrobiologyBacterial InfectionsDiagnostic BacteriologySexually Transmitted InfectionsHigh-sensitivity AssaysMultiplex Assay DesignMultiplex Assay DevelopmentMultiplex Assay ValidationNondestructive AssayTest Performance CharacteristicsUrogenital Specimen TestingVaginal Swab Testing
A multicenter clinical study was conducted to evaluate the performance characteristics of the Abbott RealTime CT/NG assay, a multiplex real-time PCR assay, for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae. The specimens were collected from a total of 3,832 male and female subjects at 16 geographically diverse sites. Specimens included male and female urine samples, male urethral swabs, female endocervical swabs, and self-collected and clinician-collected vaginal swabs. Specimens were tested with the automated Abbott RealTime CT/NG assay, Aptima Combo 2 assay (Gen-Probe), ProbeTec ET CT/GC assay (Becton Dickinson), and culture for N. gonorrhoeae. The Aptima Combo 2 assay, the ProbeTec assay, and the N. gonorrhoeae culture were used as the reference assays. For each subject, a patient infected status (PIS) was determined based on the combined results from the reference assays. The overall prevalence in female subjects was 8.9% for C. trachomatis and 3.8% for N. gonorrhoeae. The overall male prevalence was 18.2% for C. trachomatis and 16.7% for N. gonorrhoeae. The overall sensitivity and specificity of the Abbott RealTime CT/NG assay were 92.4% and 99.2% for C. trachomatis and 96.9% and 99.7% for N. gonorrhoeae, respectively. In comparison, the sensitivity and specificity, respectively, for the Aptima Combo 2 assay were 94.5% and 99.0% for C. trachomatis and 96.1% and 99.5% for N. gonorrhoeae, and those for the ProbeTec ET assay were 90.3% and 99.5% for C. trachomatis and 92.0% and 97.3% for N. gonorrhoeae in this study. The Abbott RealTime CT/NG assay offers C. trachomatis and N. gonorrhoeae dual detection with high sensitivity and specificity. The automated assay provides a useful alternative nucleic acid amplification assay for clinical laboratories and clinicians.
15
Sexually transmitted disease surveillance
Brendan H. O’Connor, HilaryE. Tillett, James Berrie et al. · BMJ · 1982 · 2.2K citations · Full text
Barbara Van Der Pol, D Ferrero, Linda Buck-Barrington et al. · Journal of Clinical Microbiology · 2001 · 288 citations · Full text
Charlotte A. Gaydos, Thomas C. Quinn, Dean Willis et al. · Journal of Clinical Microbiology · 2003 · 232 citations · Full text
Barbara Van Der Pol, Thomas C. Quinn, Charlotte A. Gaydos et al. · Journal of Clinical Microbiology · 2000 · 144 citations · Full text